1669 - A US Based National Surveillance Study for the Susceptibility and Epidemiology of Clostridioides difficile Associated Diarrheal Isolates with Special Reference to Ridinilazole: 2020-2021

Saturday, October 22, 2022

12:15 PM – 1:30 PM US ET

Location: Virtual

Co-Author(s)

LM

Laura A. McDermott, BS

Senior Research Associate
Tufts Medical Center
Boston, Massachusetts, United States
CT

Cheleste M. Thorpe, MD

Physician
Tufts Medical Center
Boston, Massachusetts, United States
EG

Ellie Goldstein, MD

MD
Kindred LA/UCLA
Los Angeles, California, United States
AS

Audrey Schuetz, MD

Associate Professor
Mayo Clinic
Rochester, Minnesota, United States
Stuart Johnson, M.D.

ID Physician and Researcher
Hines VA Hospital and Loyola University Medical Center
Hines, Illinois, United States
DG

Dale N. Gerding, MD

Research Physician
Edward Hines, Jr. Veterans Affairs Hospital
Hines, Illinois, United States
Karen C. Carroll, MD

Professor, Director, Division Medical Microbiology
Johns Hopkins University
Baltimore, Maryland, United States
Kevin W. Garey, PharmD, MS (he/him/his)

Professor and Chair
University of Houston
Houston, TX, United States
Chris Lancaster, MS

Sr. Research Manager
University of Houston
Houston, Texas, United States
SW

Seth Walk, PhD

Montana State University
Bozeman, Montana, United States
ED

Esther Duperchy, PhD

Summit Plc
Abingdon, England, United Kingdom

David R. Snydman, MD

Senior Physician
Tufts Medical Center
Boston, Massachusetts, United States